High-intensity interval training (HIIT) is currently considered one of the most effective strategies to improved cardiorespiratory fitness, which is recognized as a protective factor for cardiovascular diseases and metabolic diseases such as overweight and obesity. However, current evidence is still limited and requires clarity (frequency, time per session and intensity) regarding to greater increases attributed to HIIT.

The aim of this study is to compare the effect of a low-volume high-intensity interval training versus a moderate-intensity continuous exercise on maximal oxygen consumption in overweight women 18 to 44 years old.

Thirty-six women will be randomly assigned to one of two aerobic exercise on a real-life setting supervised for a physical activity instructor. The interventions will performed three times a week for ten-weeks (on alternate days).

The first two weeks will correspond to the conditioning period (30 minutes between 55-65% of maximum heart rate (HRmax). From week three, 18 participants will perform 30 minutes of continuous exercise at an intensity between 65-75 % of HRmax, and the remaining 18 will complete 21.5 minutes of interval exercise at an intensity between 90-95% of HRmax, with recoveries between 50-55% of HRmax.

All Participants will be evaluated to measure their maximal oxygen consumption, total body fat, waist circumference, body mass index, systolic blood pressure, diastolic blood pressure, prior to start the interventions and at the end of the program (week 11).

Inclusion Criteria:

• Overweight (≥ 25 kg/m-2) women 18 to 44 years.
• Healthy volunteers.
• Perform ≤ 600 Met/min/week.

Exclusion Criteria:

• Perform high-intensity interval exercise in the last six month.
• Smoker.
• History of asthma.
• History of diabetes.
• History of hypertension.
• History of cardiovascular disease.
• History of coronary heart disease.
• Arrhythmias.
• Personal history of surgical procedures in the last three months
• Uncontrolled non-communicable diseases
• Under medical treatment with anticoagulants, beta-blockers, calcium antagonists, bronchodilators, and/or steroids.
• Psychological, neuromotor and/or osteo-muscular conditions that may affect participation in an exercise program.
• Psychoactive drug abuse.